Suchergebnisse - "Subklewe, Marion"

PubPharm (326)

61

CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology immunotherapy | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

62

CD33 $ BiTE^{®} $ molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

enthalten in: Cancer immunology immunotherapy | 2023

von Marcinek, A. | Brauchle, B. | Rohrbacher, L. | +13

63

Reader Response : Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

enthalten in: Neurology | 2023

von Karschnia, P. | Rejeski, K. | Subklewe, M. | +1

CommentOn: Neurology. 2022 Sep 20;99(12):511-515. - PMID 35851255

64

STING agonism turns human T cells into interferon-producing cells but impedes their functionality

enthalten in: EMBO reports | 2023

von Kuhl, N. | Linder, A. | Philipp, N. | +9

65

Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML

enthalten in: Blood | 2023

von Roas, M. | Vick, B. | Kasper, M. | +21

66

WT1 and DNMT3A play essential roles in the growth of certain patient AML cells in mice

enthalten in: Blood | 2023

von Ghalandary, M. | Gao, Y. | Amend, D. | +11

67

Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma : the GLA/DRST experience

enthalten in: Bone marrow transplantation | 2023

von Dreger, P. | Holtick, U. | Subklewe, M. | +22

68

Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia

enthalten in: Infection | 2023

von Ruzicka, M. | Wurm, S. | Lindner, L. | +9

69

MESOTHELIN ANTIBODIES AND USE THEREOF

enthalten in: Europäisches Patentamt | 2023

von HOPFNER KARL-PETER | SUBKLEWE MARION | WYDER PETERS LORENZA | +6

70

ANTI-CD47 ANTIBODIES AND USE THEREOF

enthalten in: Europäisches Patentamt | 2023

von HOPFNER KARL-PETER | SUBKLEWE MARION | SCHELE ALEXANDRA | +6